Filter By Industry
Filter By Tag

Newsroom

Otava Ltd. Press releases

1 - 10 of 10 Press Releases

Aug 04, 2011
Alzheimer’s disease (AD) is a devastating and always fatal neurodegenerative disorder characterized by progressive impairment of cognitive function and emotional disturbances. Currently, more than 25 million people worldwide live with AD.

Jul 01, 2011
There are many different drug targets expressed in brain tissue. The delivery of drugs to central nervous system (CNS) is complicated by blood brain barrier (BBB) which controls entry of drugs into CNS.

Jun 06, 2011
The preclinical drug-discovery process requires the screening of millions of small organic molecules to find a suitable lead compound for one ultimately successful outcome.

Mar 23, 2011
Biologically active molecule is a broad term comprising a variety of compounds possessing biological activity.Our company, OTAVA Ltd., provides a wide range of biologically active compounds modulating activity of distinct targets.

Feb 07, 2011
In recent years, remarkable progress has been made and miraculous results produced in the field of synthetic chemistry. However, searching for desired chemical compounds among variety of chemical databases becomes more and more complex.

Aug 18, 2010
The challenging question of the modern pharmaceutical industry is why do fragments hits provide a new paradigm for drug discovery of some targets? In this white paper we describe the advantages of the fragment-based approach in search for new drugs.

Aug 18, 2010
The objective of this report is to give some insight on using chemical building blocks that allow generating diversity and complexity in chemical structures.

Aug 18, 2010
Using special focused libraries of chemical compounds in drug design is becoming increasingly common. Here we describe different kinds of focused compound libraries that can be used in medicinal chemistry.

Aug 18, 2010
To identify promising leads for potentially marketable drugs requires large compound libraries. In this white paper we would like to discuss some aspects of high-throughput screening (HTS) compound libraries used in drug discovery process.

Jul 14, 2010
OTAVA Ltd. offers a new set of target-focused libraries with Enhanced Intellectual Property Potential (EIPL®).


Otava Ltd. RSS Feed